Stream Biomedical, Inc. — Form D
Stream Biomedical, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-10. The offering totals $21.5M, of which $21.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-01-10
- Form: D
- Accession: 0001900573-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $21.5M
- Amount sold: $21.5M
- Minimum investment: $50K
- Investors: 11
- Date of first sale: 2021-12-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-428508
Issuer
- Name: Stream Biomedical, Inc.
- CIK: 0001900573
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2450 HOLCOMBE BOULEVARD, HOUSTON, TX, 77021
- Phone: (713) 965-4429
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Fred Callori | Director | Houston, TX |
| Amanda De La Garza | Director | Houston, TX |
| Chris Garabedian | Director | San Francisco, CA |
| William Schwieterman | Director | Houston, TX |
| William Schwieterman | Executive Officer | Houston, TX |
More